Bioscience Technology

Product Releases

Transfection Reagent Delivers High Performance Transfection Across Multiple Cell Lines
Fri, 01/17/2014 - 11:57am

LISTED UNDER:

Promega announces ViaFect Transfection Reagent, a tool for efficient DNA transfer into a wide variety of cell lines, including challenging suspension cells and stem cell-derived lines. ViaFect Transfection Reagent allows researchers to develop transfection-based assays in the cell line most relevant for their biology of interest.

Induced pluripotent stem cell (iPSC)-derived cell models, such as Cellular Dynamics International's iCell Cardiomyocytes, show robust transfection with ViaFect Transfection Reagent, enabling assays not possible with other reagents. ViaFect Transfection Reagent offers high performance transfection in a diversity of cell lines and iPSC-derived tissue cells. This low toxicity reagent allows cells to stay healthy and metabolically active during transfection-based experiments, even at low cell densities, facilitating experiments where extended application of a treatment is needed. Cell viabilities of greater than 90% are routinely observed following transfection with ViaFect Transfection Reagent.

ViaFect Transfection Reagent requires minimal optimization with a simple three-step protocol. It does not require removal of serum, removal of culture medium or washing after introduction of the reagent/DNA complex. ViaFect Transfection Reagent contains no animal-derived components.

Promega Corp., 800-356-9526, www.promega.com

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading